216 related articles for article (PubMed ID: 11412101)
21. A model of reversible inhibitors in the gastric H+/K+-ATPase binding site determined by rotational echo double resonance NMR.
Watts JA; Watts A; Middleton DA
J Biol Chem; 2001 Nov; 276(46):43197-204. PubMed ID: 11479301
[TBL] [Abstract][Full Text] [Related]
22. SCH28080 prevents omeprazole inhibition of the gastric H+/K+-ATPase.
Hersey SJ; Steiner L; Mendlein J; Rabon E; Sachs G
Biochim Biophys Acta; 1988 Aug; 956(1):49-57. PubMed ID: 2841979
[TBL] [Abstract][Full Text] [Related]
23. Mimicking of K+ activation by double mutation of glutamate 795 and glutamate 820 of gastric H+,K+-ATPase.
Hermsen HP; Swarts HG; Wassink L; Koenderink JB; Willems PH; De Pont JJ
Biochemistry; 2001 May; 40(21):6527-33. PubMed ID: 11371216
[TBL] [Abstract][Full Text] [Related]
24. Functional consequences of the oligomeric form of the membrane-bound gastric H,K-ATPase.
Shin JM; Grundler G; Senn-Bilfinger J; Simon WA; Sachs G
Biochemistry; 2005 Dec; 44(49):16321-32. PubMed ID: 16331993
[TBL] [Abstract][Full Text] [Related]
25. Role of negatively charged residues in the fifth and sixth transmembrane domains of the catalytic subunit of gastric H+,K+-ATPase.
Swarts HG; Klaassen CH; de Boer M; Fransen JA; De Pont JJ
J Biol Chem; 1996 Nov; 271(47):29764-72. PubMed ID: 8939913
[TBL] [Abstract][Full Text] [Related]
26. E2P state stabilization by the N-terminal tail of the H,K-ATPase beta-subunit is critical for efficient proton pumping under in vivo conditions.
Dürr KL; Abe K; Tavraz NN; Friedrich T
J Biol Chem; 2009 Jul; 284(30):20147-54. PubMed ID: 19491099
[TBL] [Abstract][Full Text] [Related]
27. Amino acids Val115-Ile126 of rat gastric H(+)-K(+)-ATPase confer high affinity for Sch-28080 to Na(+)-K(+)-ATPase.
Lyu RM; Farley RA
Am J Physiol; 1997 May; 272(5 Pt 1):C1717-25. PubMed ID: 9176164
[TBL] [Abstract][Full Text] [Related]
28. Functional properties of an H,K-ATPase/Na,K-ATPase chimera.
Blostein R; Zhang R; Gottardi CJ; Caplan MJ
J Biol Chem; 1993 May; 268(14):10654-8. PubMed ID: 8387526
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of the putative K(+)-binding site on the fourth transmembrane segment of the gastric H(+),K(+)-ATPase.
Asano S; Furumoto R; Tega Y; Matsuda S; Takeguchi N
J Biochem; 2000 Jun; 127(6):993-1000. PubMed ID: 10833267
[TBL] [Abstract][Full Text] [Related]
30. Studies on the mechanism of action of the gastric H+,K(+)-ATPase inhibitor SPI-447.
Tsukimi Y; Ushiro T; Yamazaki T; Ishikawa H; Hirase J; Narita M; Nishigaito T; Banno K; Ichihara T; Tanaka H
Jpn J Pharmacol; 2000 Jan; 82(1):21-8. PubMed ID: 10874584
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of action of AZD0865, a K+-competitive inhibitor of gastric H+,K+-ATPase.
Gedda K; Briving C; Svensson K; Maxvall I; Andersson K
Biochem Pharmacol; 2007 Jan; 73(2):198-205. PubMed ID: 17081503
[TBL] [Abstract][Full Text] [Related]
32. Involvement of glutamic acid 820 in K+ and SCH 28080 binding to gastric H+,K(+)-ATPase.
Swarts HP; Klaassen CH; De Pont JJ
Ann N Y Acad Sci; 1997 Nov; 834():472-4. PubMed ID: 9405848
[No Abstract] [Full Text] [Related]
33. Properties of the reversible K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. I. In vitro activity.
Pope AJ; Boehm MK; Leach C; Ife RJ; Keeling D; Parsons ME
Biochem Pharmacol; 1995 Nov; 50(10):1543-9. PubMed ID: 7503755
[TBL] [Abstract][Full Text] [Related]
34. The gastric H,K ATPase as a drug target: past, present, and future.
Sachs G; Shin JM; Vagin O; Lambrecht N; Yakubov I; Munson K
J Clin Gastroenterol; 2007 Jul; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
[TBL] [Abstract][Full Text] [Related]
35. Soraprazan: setting new standards in inhibition of gastric acid secretion.
Simon WA; Herrmann M; Klein T; Shin JM; Huber R; Senn-Bilfinger J; Postius S
J Pharmacol Exp Ther; 2007 Jun; 321(3):866-74. PubMed ID: 17369284
[TBL] [Abstract][Full Text] [Related]
36. Conformation-dependent inhibition of gastric H+,K+-ATPase by SCH 28080 demonstrated by mutagenesis of glutamic acid 820.
Swarts HG; Hermsen HP; Koenderink JB; Willems PH; de Pont JJ
Mol Pharmacol; 1999 Mar; 55(3):541-7. PubMed ID: 10051539
[TBL] [Abstract][Full Text] [Related]
37. Arginine substitution of a cysteine in transmembrane helix M8 converts Na+,K+-ATPase to an electroneutral pump similar to H+,K+-ATPase.
Holm R; Khandelwal J; Einholm AP; Andersen JP; Artigas P; Vilsen B
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):316-321. PubMed ID: 28028214
[TBL] [Abstract][Full Text] [Related]
38. Chemomechanical coupling in the gastric H,K ATPase.
Besancon M; Shin JM; Mercier F; Munson K; Rabon E; Hersey S; Sachs G
Acta Physiol Scand Suppl; 1992; 607():77-88. PubMed ID: 1333163
[TBL] [Abstract][Full Text] [Related]
39. Conversion of the low affinity ouabain-binding site of non-gastric H,K-ATPase into a high affinity binding site by substitution of only five amino acids.
Qiu LY; Swarts HGP; Tonk ECM; Willems PHGM; Koenderink JB; De Pont JJHHM
J Biol Chem; 2006 May; 281(19):13533-13539. PubMed ID: 16531406
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of gastric H+/K+-ATPase by substituted imidazo[1,2-a]pyridines.
Briving C; Andersson BM; Nordberg P; Wallmark B
Biochim Biophys Acta; 1988 Dec; 946(2):185-92. PubMed ID: 2850003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
